As of May 27, 2025, Curaleaf Holdings Inc (CURA.CN) reports a EV/EBITDA of 178.34.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing Curaleaf Holdings Inc's EV/EBITDA to Peers
To better understand Curaleaf Holdings Inc's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
| Company | EV/EBITDA |
|---|---|
| Curaleaf Holdings Inc (CURA.CN) | 178.34 |
| Pacira Biosciences Inc (PCRX) | 68.77 |
| Corcept Therapeutics Inc (CORT) | 59.42 |
| Catalent Inc (CTLT) | 45.03 |
| SNDL Inc (SNDL) | 35.94 |
| Horizon Therapeutics PLC (HZNP) | 29.60 |
Compared to its competitors, Curaleaf Holdings Inc's EV/EBITDA is higher than all peers, suggesting the market values the company at a premium, possibly due to growth expectations.